Cite
MLA Citation
Suresh S. Ramalingam et al.. “JASPER: Phase 2 trial of first‐line niraparib plus pembrolizumab in patients with advanced non–small cell lung cancer.” Cancer, vol. 128, no. 1, 2022, pp. 65–74. http://access.bl.uk/ark:/81055/vdc_100147225959.0x00005e